Citadel Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$944K Buy
767,561
+610,629
+389% +$751K ﹤0.01% 3372
2025
Q1
$173K Buy
156,932
+16,925
+12% +$18.6K ﹤0.01% 4931
2024
Q4
$127K Sell
140,007
-900,046
-87% -$814K ﹤0.01% 5078
2024
Q3
$1.03M Sell
1,040,053
-3,053,783
-75% -$3.01M ﹤0.01% 3084
2024
Q2
$3.69M Buy
4,093,836
+219,110
+6% +$197K ﹤0.01% 1919
2024
Q1
$4.57M Sell
3,874,726
-2,265,506
-37% -$2.67M ﹤0.01% 1815
2023
Q4
$5.6M Sell
6,140,232
-27,911
-0.5% -$25.5K ﹤0.01% 1577
2023
Q3
$5.14M Buy
6,168,143
+4,741,674
+332% +$3.95M ﹤0.01% 1597
2023
Q2
$1.71M Sell
1,426,469
-1,368,248
-49% -$1.64M ﹤0.01% 2555
2023
Q1
$3.52M Buy
+2,794,717
New +$3.52M ﹤0.01% 2080
2022
Q4
Sell
-731,264
Closed -$8.76M 6303
2022
Q3
$8.76M Sell
731,264
-1,551,585
-68% -$18.6M ﹤0.01% 1381
2022
Q2
$19.1M Buy
2,282,849
+138,538
+6% +$1.16M ﹤0.01% 856
2022
Q1
$18.6M Buy
2,144,311
+268,560
+14% +$2.33M ﹤0.01% 959
2021
Q4
$21.2M Buy
1,875,751
+287,800
+18% +$3.25M ﹤0.01% 894
2021
Q3
$20M Buy
1,587,951
+1,572,150
+9,950% +$19.8M ﹤0.01% 902
2021
Q2
$128K Sell
15,801
-564,995
-97% -$4.58M ﹤0.01% 5843
2021
Q1
$5.37M Sell
580,796
-189,962
-25% -$1.76M ﹤0.01% 2011
2020
Q4
$7.45M Buy
770,758
+691,286
+870% +$6.69M ﹤0.01% 1454
2020
Q3
$986K Buy
79,472
+33,286
+72% +$413K ﹤0.01% 2937
2020
Q2
$600K Sell
46,186
-268,266
-85% -$3.49M ﹤0.01% 3307
2020
Q1
$3.19M Buy
314,452
+272,828
+655% +$2.77M ﹤0.01% 1803
2019
Q4
$650K Sell
41,624
-881,320
-95% -$13.8M ﹤0.01% 3357
2019
Q3
$15.5M Sell
922,944
-3,978
-0.4% -$66.8K 0.01% 937
2019
Q2
$20.6M Sell
926,922
-45,651
-5% -$1.01M 0.01% 784
2019
Q1
$21.1M Buy
+972,573
New +$21.1M 0.01% 722